The Chemours Company (CC) Spending and interest coverage
- R&D / revenue · 12 months: Value 1.83%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 0.40%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Operating income ÷ reported interest expense..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 1.83% | Research and development expense / revenue. Period ending 2026-06-30. $106.00M ÷ $5.80B × 100 ≈ 1.83% |
| Stock-based compensation / revenue · 12 months | 0.40% | Share-based compensation / revenue. Period ending 2026-06-30. $23.00M ÷ $5.80B × 100 ≈ 0.40% |
| Interest coverage · 12 months | (m) | Operating income ÷ reported interest expense. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 106.00M USD | Research and Development Expense |
| Revenue | 5.80B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 23.00M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | (m) | |
| Interest expense · reported / estimated | 273.00M USD | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: Reported. Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $106.00M | $5.80B | $23.00M | (m) | $273.00M | 1.83% | 0.40% | (m) | Reported |
| 2026-03-31 | $107.00M | $5.82B | $23.00M | (m) | $272.00M | 1.84% | 0.40% | (m) | Reported |
| 2025-12-31 | $108.00M | $5.81B | $21.00M | (m) | $269.00M | 1.86% | 0.36% | (m) | Reported |
| 2025-09-30 | $107.00M | $5.84B | $20.00M | (m) | $268.00M | 1.83% | 0.34% | (m) | Reported |
| 2025-06-30 | $111.00M | $5.85B | $20.00M | (m) | $268.00M | 1.90% | 0.34% | (m) | Reported |
| 2025-03-31 | $108.00M | $5.79B | $19.00M | (m) | $266.00M | 1.87% | 0.33% | (m) | Reported |
| 2024-12-31 | $109.00M | $5.78B | $15.00M | (m) | $264.00M | 1.89% | 0.26% | (m) | Reported |
| 2024-09-30 | $109.00M | $5.75B | $17.00M | (m) | $260.00M | 1.90% | 0.30% | (m) | Reported |
| 2024-06-30 | $107.00M | $5.74B | $18.00M | (m) | $246.00M | 1.87% | 0.31% | (m) | Reported |
| 2024-03-31 | $110.00M | $5.84B | $15.00M | (m) | $229.00M | 1.88% | 0.26% | (m) | Reported |
| 2023-12-31 | $108.00M | $6.03B | $18.00M | (m) | $208.00M | 1.79% | 0.30% | (m) | Reported |
| 2023-09-30 | $112.00M | $6.00B | $16.00M | (m) | $185.00M | 1.87% | 0.27% | (m) | Reported |
| 2023-06-30 | $117.00M | $6.29B | $17.00M | (m) | $171.00M | 1.86% | 0.27% | (m) | Reported |
| 2023-03-31 | $114.00M | $6.57B | $21.00M | (m) | $164.00M | 1.74% | 0.32% | (m) | Reported |
| 2022-12-31 | $118.00M | $6.79B | $27.00M | (m) | $163.00M | 1.74% | 0.40% | (m) | Reported |
| 2022-09-30 | $117.00M | $7.03B | $34.00M | (m) | $166.00M | 1.66% | 0.48% | (m) | Reported |
| 2022-06-30 | $111.00M | $6.93B | $31.00M | (m) | $170.00M | 1.60% | 0.45% | (m) | Reported |
| 2022-03-31 | $113.00M | $6.67B | $32.00M | (m) | $177.00M | 1.69% | 0.48% | (m) | Reported |
| 2021-12-31 | $107.00M | $6.34B | $34.00M | (m) | $185.00M | 1.69% | 0.54% | (m) | Reported |
| 2021-09-30 | $104.00M | $6.11B | $28.00M | (m) | $192.00M | 1.70% | 0.46% | (m) | Reported |
| 2021-06-30 | $100.00M | $5.66B | $27.00M | (m) | $200.00M | 1.77% | 0.48% | (m) | Reported |
| 2021-03-31 | $93.00M | $5.10B | $20.00M | (m) | $205.00M | 1.82% | 0.39% | (m) | Reported |
| 2020-12-31 | $93.00M | $4.97B | $16.00M | (m) | $210.00M | 1.87% | 0.32% | (m) | Reported |
| 2020-09-30 | $86.00M | $4.98B | $13.00M | (m) | $212.00M | 1.73% | 0.26% | (m) | Reported |
| 2020-06-30 | $83.00M | $5.14B | $14.00M | (m) | $212.00M | 1.61% | 0.27% | (m) | Reported |
| 2020-03-31 | $82.00M | $5.46B | $19.00M | (m) | $211.00M | 1.50% | 0.35% | (m) | Reported |
| 2019-12-31 | $80.00M | $5.53B | $19.00M | (m) | $208.00M | 1.45% | 0.34% | (m) | Reported |
| 2019-09-30 | $82.00M | $5.64B | (m) | (m) | $203.00M | 1.45% | (m) | (m) | Reported |
| 2019-06-30 | $83.00M | $5.88B | (m) | (m) | $198.00M | 1.41% | (m) | (m) | Reported |
| 2019-03-31 | $84.00M | $6.28B | (m) | (m) | $194.00M | 1.34% | (m) | (m) | Reported |
| 2018-12-31 | $82.00M | $6.64B | (m) | (m) | $195.00M | 1.24% | (m) | (m) | Reported |
| 2018-09-30 | $79.00M | $6.75B | (m) | (m) | $203.00M | 1.17% | (m) | (m) | Reported |
| 2018-06-30 | $79.00M | $6.71B | (m) | (m) | $210.00M | 1.18% | (m) | (m) | Reported |
| 2018-03-31 | $81.00M | $6.48B | (m) | (m) | $216.00M | 1.25% | (m) | (m) | Reported |
| 2017-12-31 | $80.00M | $6.18B | (m) | (m) | $215.00M | 1.29% | (m) | (m) | Reported |
| 2017-09-30 | $81.00M | $5.93B | (m) | (m) | $217.00M | 1.37% | (m) | (m) | Reported |
| 2017-06-30 | $80.00M | $5.74B | (m) | (m) | $213.00M | 1.39% | (m) | (m) | Reported |
| 2017-03-31 | $76.00M | $5.54B | (m) | (m) | $207.00M | 1.37% | (m) | (m) | Reported |
| 2016-12-31 | $80.00M | $5.40B | (m) | (m) | $213.00M | 1.48% | (m) | (m) | Reported |
| 2016-09-30 | $89.00M | $5.44B | (m) | (m) | $210.00M | 1.64% | (m) | (m) | Reported |
| 2016-06-30 | $87.00M | (m) | (m) | (m) | $210.00M | (m) | (m) | (m) | Reported |
| 2016-03-31 | $97.00M | $5.65B | (m) | (m) | $189.00M | 1.72% | (m) | (m) | Reported |
| 2015-12-31 | $97.00M | $5.72B | (m) | (m) | $132.00M | 1.70% | (m) | (m) | Reported |
| 2015-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | $6.23B | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | $143.00M | $6.43B | (m) | (m) | $0.00 | 2.22% | (m) | (m) | Reported |
| 2014-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | $164.00M | $6.86B | (m) | (m) | $0.00 | 2.39% | (m) | (m) | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INNOSPEC INC. (IOSP) | United States | $2.380B | 16.37 |
| OLIN Corp (OLN) | United States | $1.852B | -11.54 |
| Ingevity Corp (NGVT) | United States | $2.468B | 47.72 |
| Huntsman CORP (HUN) | United States | $1.540B | -6.95 |
| FMC CORP (FMC) | United States | $1.201B | -0.52 |
| Ecovyst Inc. (ECVT) | United States | $1.110B | -22.22 |
| ASCENT INDUSTRIES CO. (ACNT) | United States | $0.132B | -30.55 |
| CitroTech Inc. (CITR) | United States | $0.097B | -5.12 |
| Loop Industries, Inc. (LOOP) | $0.023B | -5.50 | |
| GULF RESOURCES, INC. (GURE) | $0.006B |